Skip to content
Clinical Trials – home
Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif
Sponsor

Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif

France 50 Rue Richer, 75009 Paris, France

About the sponsor

Research activity in Crohn’s disease includes treatment strategies aimed at transmural response and deeper control of intestinal inflammation, with attention to endoscopic healing and disease activity in the small and large bowel.

  • Transmural response
  • Endoscopic healing
  • Intestinal inflammation

The sponsor also supports work in patients with moderate to severe Crohn’s disease, reflecting a focus on active disease requiring advanced therapeutic management.

About Specializations

Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif runs clinical trials in conditions such as Crohn's disease, Colitis ulcerative, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Guselkumab
  • Sponsor:Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.